the value of sustained mrd negativity in mm
Published 2 years ago • 42 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
2:00
sustained mrd negativity in mm with lenalidomide maintenance
-
0:55
sustained mrd negativity in multiple myeloma
-
3:14
the prognostic value of mrd negativity
-
1:57
mrd negativity in all
-
4:16
the prognostic value of mrd in multiple myeloma & mrd-guided therapy
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
3:07
minimal residual disease (mrd)
-
1:05:07
euretina case club with prof adnan tufail (nov 10th, 2021)
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:28
mrd negativity in myeloma patients undergoing maintenance therapy
-
1:16
perspectives on the role of mrd negativity in multiple myeloma
-
3:05
mrd negativity assessed by flow cytometry associated with improved outcomes in npm1-mutated aml
-
1:55
predictors of unsustained mrd negativity in multiple myeloma
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
3:27
mrd negativity using deep sequencing is a major prognostic factor in myeloma
-
1:10
should we adapt treatment based on mrd status in mm?
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:26
mrd in myeloma: the fda perspective
-
1:19
al amyloidosis: mrd negativity
-
4:14
cd16, cd57 and dnam-1 positive nk cells predict mrd negativity in mm treated with d-vtd
-
1:23
the value of mrd as a marker for disease eradication in aml